Filing Flows

Filing Flows › Companies › Health In Tech › Cash flow

Health In Tech cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$2.9M in Q2 2026 · −$5.1M over twelve months

Operating cash flow−$2.9M
Free cash flow−$2.9M
Cash conversion cycle-116 days

Analysis

In Q2 2026, Health In Tech generated −$2.9M of operating cash flow. That is $4.4M less than in Q2 2025 ($1.5M).

Over the twelve months to Jun 30, 2026, operating cash flow was −$5.1M; the largest uses were operating cash flow ($5.1M), other investing ($2.5M); besides operations, cash came from other financing ($6.0M); the cash balance fell by $1.6M.

Operating cash flow was −$2.9M against net income of −$2.5M. The largest differences: receivables −$4.8M, payables +$2.9M, stock-based pay +$959K.

Its cash conversion cycle was -116 days (receivables 69 + inventory 0 − payables 186): suppliers fund its working capital.

Free cash flow

Health In Tech: free cash flow by quarterHealth In Tech: free cash flow by quarter$2.1MQ3 2024−$531KQ4 2024$527KQ1 2025$1.5MQ2 2025$674KQ3 2025$451KQ4 2025−$3.3MQ1 2026−$2.9MQ2 2026
Operating cash flow less capital spending.
Health In Tech: operating cash flow against capital spendingHealth In Tech: operating cash flow against capital spendingOperating cash flowCapital spending$2.1M$0Q3 2024−$531K$0Q4 2024$527K$0Q1 2025$1.5M$0Q2 2025$674K$0Q3 2025$451K$0Q4 2025−$3.3M$0Q1 2026−$2.9M$0Q2 2026
Latest (Q2 2026): Operating cash flow −$2.9M, Capital spending $0.

Capital allocation, year by year

Health In Tech: where the cash came from (up) and went (down), by fiscal yearHealth In Tech: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedFY2023: Operating cash flow $1.5MFY2023: Net borrowing $1.6M$3.2MFY2023FY2024: Operating cash flow $2.2MFY2024: Net borrowing −$2.1MFY2024: Shares issued $8.2M$10.4MFY2024FY2025: Operating cash flow $3.1MFY2025: Shares issued $23K$3.2MFY2025
Over these 3 years operating cash flow totalled $6.8M; the largest uses were net borrowing ($2.1M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$6.5M
Debtnone
Net cash$6.5M
Cash runway15 months

Health In Tech is burning cash: its operations consume cash, a free cash flow of −$5.1M a year at the current rate against $6.5M of cash and investments: a runway of about 15 months before any new financing.

Where the cash came from and went

Health In Tech: sources (+) and uses (−) of cash, Q2 2026Health In Tech: sources (+) and uses (−) of cash, Q2 2026Cash drawn (+) / kept (−)$3.8MOperating cash flow−$2.9MOther investing−$597KOther financing−$301K
Health In Tech: sources (+) and uses (−) of cash, TTM to Q2 2026Health In Tech: sources (+) and uses (−) of cash, TTM to Q2 2026Other financing$6.0MOperating cash flow−$5.1MOther investing−$2.5MCash drawn (+) / kept (−)$1.6M

From profit to cash

Health In Tech: net income to operating cash flow, Q2 2026Health In Tech: net income to operating cash flow, Q2 2026Net income−$2.5MDepreciation & amortization$320KStock-based pay$959KDeferred taxes−$814KReceivables−$4.8MPayables$2.9MPrepaid and other assets$350KOperating cash flow−$2.9M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 202669—186-116
Q1 202623—118-95
Q4 202510—115-106
Q3 202512—119-107
Q2 202517—149-132
Q1 202521—124-103

Every quarter

QuarterOperating cash flowShares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$2.9M—$3.8M−$2.9M
Q1 2026−$3.3M$6.4M−$2.7M−$3.3M
Q4 2025$451K—$354K$451K
Q3 2025$674K—$115K$674K
Q2 2025$1.5M—−$563K$1.5M
Q1 2025$527K$8.2M$274K$527K
Q4 2024−$531K—−$6.1M−$531K
Q3 2024$2.1M—$416K$2.1M

Health In Tech: income statement and cash flow

Health In Tech, Q2 2026: revenue $8.1M (-14% year over year), operating margin -41.2%. The chart follows the revenue to costs, profit and cash.

Health In Tech: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.